Patterson Companies, Inc. announced that Donald J. Zurbay, most recently the Company's Chief Financial Officer, has been named Chief Executive Officer of the Company, effective October 12, 2022. The Company's Board of Directors made such appointment upon the resignation of Mark S. Walchirk as Chief Executive Officer of the Company. The Company also announced that Kevin Barry, most recently the Company's Vice President, Finance and Corporate Controller, has been named interim Chief Financial Officer of the Company, effective immediately, thereby replacing Mr. Zurbay in that role.

Mr. Zurbay, age 55, became the Company's Chief Financial Officer in June 2018. Prior to joining the Company, Mr. Zurbay served as Vice President and Chief Financial Officer at St. Jude Medical, Inc., a global medical device manufacturer, from August 2012 through the January 2017 acquisition of SJM by Abbott Laboratories.

Mr. Zurbay joined SJM in 2003, held various leadership positions including Director of Finance and Vice President and Corporate Controller, and ultimately became responsible for all of their accounting, financial and business development activities. Prior to joining SJM, Mr. Zurbay worked at PricewaterhouseCoopers, The Valspar Corporation and Deloitte & Touche. In terms of public company board service, Mr. Zurbay served as a director of Avedro, Inc. from its February 2019 initial public offering through its November 2019 sale.

He currently serves as a director of Silk Road Medical, Inc. since March 2018 and as a director of Sight Sciences, Inc. since July 2020. Mr. Barry, age 44, became the Company's Vice President, Finance and Controller in 2020 and previously served as the Company's Vice President, Finance Operations and Strategy from 2018 through 2020 and Vice President and Chief Financial Officer of Patterson Dental from 2017 to 2018. Prior to joining the Company, Mr. Barry served as Finance Director of an operating unit of General Mills, Inc., a global manufacturer and marketer of branded consumer foods, from 2015 through 2017.

Mr. Barry joined GM in 2005, held various leadership positions including Senior Finance Manager. At GM, Mr. Barry was responsible for the finance and IT functions of an operating unit focused on natural and organic food. Prior to joining GM, Mr. Barry worked at Jones Lang Lasalle, Inc. He currently serves as a director of Strategic Pharmaceutical Solutions Inc. and Oral Health America, both privately owned companies.